+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
TITANBIO TITANBIO

Titan Biotech Share Price

₹399.50 -0.05 (-0.01%)
28.10% Fall from 52W High

23 Sep, 2026 4:01 PM (IST)

Titan Biotech live price: ₹399.50. It opened at ₹400 vs previous close ₹400; intraday high/low: ₹410/₹390. The 50 & 200 DMA stand at ₹408.60/₹358.20.

Titan Biotech Performance

  • Today's Low
  • ₹390
  • Today's High
  • ₹410
  • 52 Week Low
  • ₹171
  • 52 Week High
  • ₹556
  • Open Price₹400
  • Previous Close₹400
  • Volume27,923
  • 50 DMA₹408.60
  • 100 DMA₹401.00
  • 200 DMA₹358.20

Titan Biotech Chart

Investment Returns

  • Over 1 Month + 0.03%
  • Over 3 Month -4.35%
  • Over 6 Month + 3.12%
  • Over 1 Year + 100.49%

Smart Investing Starts Here Start SIP with Titan Biotech for Steady Growth!

Invest Now

Titan Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 48.7
  • PEG Ratio
  • 0.9
  • Market Cap Cr
  • 1,651
  • P/B Ratio
  • 8.6
  • Average True Range
  • 20.5
  • EPS
  • 8.2
  • Dividend Yield
  • 0.1
  • MACD Signal
  • 0.3
  • RSI
  • 45.48
  • MFI
  • 65.19

Latest Stock News Updates

Titan Biotech Ltd - 524717 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Notice of Loss of Share Certificate-Disclosure under Regulation 30 of SEBI ( Listing Obligation and Disclosure Requirements) Regulations, 2015

Titan Biotech Ltd - 524717 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication regarding Notice of 34th Annual General Meeting, E-Voting and other related information

Titan Biotech Ltd - 524717 - Intimation Regarding Weblink To Access The Annual Report For FY 2025-26 And Notice Of The 34Th Annual General Meeting For Shareholders Whose Email Ids Are Not Registered

The Company has sent Letters to those members who have not registered their email address with the Company/RTA/ Depository providing a weblink including exact path of Website to access the Annual report for FY 2025-26 and Notice of 34th Annual General Meeting.

Titan Biotech Financials

Titan Biotech Technicals

EMA & SMA

Current Price
₹399.50
-0.05 (-0.01%)
pointer
  • Bearish Moving Average 14
  • Bullish Moving Average 2
  • 20 Day
  • ₹408.00
  • 50 Day
  • ₹408.60
  • 100 Day
  • ₹401.00
  • 200 Day
  • ₹358.20

Resistance and Support

399.83 Pivot Speed
  • R3 428.60
  • R2 419.20
  • R1 408.60
  • S1 388.60
  • S2 379.40
  • S3 368.70

Titan Biotech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-09-03 Bonus issue
2026-08-13 Quarterly Results
2026-05-30 Audited Results & Final Dividend
2026-02-12 Quarterly Results
2025-11-29 Stock Split
Date Purpose Remarks
2026-09-22 FINAL Rs.0.50 per share(25%)Final Dividend
2025-09-19 FINAL Rs.2.00 per share(20%)Final Dividend
View Titan Biotech Dividend History Arrow
Date Purpose Remarks
2026-02-20 Split Stock split from Rs. 10/- to Rs. 2/-.

Titan Biotech Shareholding Pattern

55.78%
44.21%
0.01%

About Titan Biotech

Titan Biotech is one of the leading manufacturer and exporter of the Biological products which are used in the field of Pharmaceuticals, Nutraceutical, Food & Beverages, Bio-technology & Fermentation, Cosmetic,Veterinary & Animal Feed etc. View More
  • NSE Symbol
  • TITANBIO
  • BSE Symbol
  • 524717
  • ISIN
  • INE150C01029

Similar Stocks to Titan Biotech

Titan Biotech FAQs

Titan Biotech share price is ₹399 As on 24 September, 2026 | 07:37

The Market Cap of Titan Biotech is ₹1650.7 Cr As on 24 September, 2026 | 07:37

The P/E ratio of Titan Biotech is 48.7 As on 24 September, 2026 | 07:37

The PB ratio of Titan Biotech is 8.6 As on 24 September, 2026 | 07:37

The 52 week High & Low of Titan Biotech is ₹555.6/₹171.4 respectively As on 24 September, 2026 | 07:37

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23